JOINT-STOCK COMPANY "NATSIONALNAYA IMMUNOBIOLOGICHESKAYA COMPANY" re-registered selling prices of 8 vaccines

Farmholding JOINT-STOCK COMPANY "NATSIONALNAYA IMMUNOBIOLOGICHESKAYA COMPANY" (JOINT-STOCK COMPANY "NATSIONALNAYA IMMUNOBIOLOGICHESKAYA COMPANY") achieved increase in limit selling prices at eight NPO Mikrogen made by affiliated JSC <1> vaccines. The cost of three more preparations is under consideration. The previous price ruler on the specified vaccines in companies called unprofitable. In JOINT-STOCK COMPANY "NATSIONALNAYA IMMUNOBIOLOGICHESKAYA COMPANY" explain that throughout long time production and realization of vaccines were unprofitable owing to low limit selling prices. The cost of a dose did not pay back costs of ampoules for pouring, add in holding. "The reconsidered prices of vaccines of FEDERAL STATE UNITARY ENTERPRISE "SCIENTIFIC PRODUCTION ASSOCIATION "MIKROGEN" MINISTRY OF HEALTH RUSSIA are called...